Abstract
Pleural lipoma is an extremely rare benign tumor. A lesion homogeneity with smooth borders is a suggestive criterion of lipoma in the chest radiology. Tissue biopsy is usually required for the diagnosis and exclusion of liposarcoma. In this case report, we described a female patient diagnosed with a pleural lipoma which was discovered accidentally during a metastatic work up of a previously diagnosed squamous cell carcinoma in the left ala nasi. The diagnosis of the pleural lipoma was histopathologically confirmed with tru cut biopsy.
Keywords: Intrathoracic lipoma, pleural lipoma, pleural tumor, tissue biopsy, liposarcoma, patient.
Current Respiratory Medicine Reviews
Title:Large Pleural Lipoma: An Incidental Finding During a Metastatic Workup
Volume: 14 Issue: 2
Author(s): Tamer Elhadidy, Raed Ali Elmetwally, Mohamed Tohlob, Mohamed Hamoda, Asem A. Hewidy and Ahmed Ehab*
Affiliation:
- Department of Chest Medicine, Faculty of Medicine, Mansoura University, Mansoura,Egypt
Keywords: Intrathoracic lipoma, pleural lipoma, pleural tumor, tissue biopsy, liposarcoma, patient.
Abstract: Pleural lipoma is an extremely rare benign tumor. A lesion homogeneity with smooth borders is a suggestive criterion of lipoma in the chest radiology. Tissue biopsy is usually required for the diagnosis and exclusion of liposarcoma. In this case report, we described a female patient diagnosed with a pleural lipoma which was discovered accidentally during a metastatic work up of a previously diagnosed squamous cell carcinoma in the left ala nasi. The diagnosis of the pleural lipoma was histopathologically confirmed with tru cut biopsy.
Export Options
About this article
Cite this article as:
Elhadidy Tamer, Elmetwally Ali Raed , Tohlob Mohamed, Hamoda Mohamed , Hewidy A. Asem and Ehab Ahmed*, Large Pleural Lipoma: An Incidental Finding During a Metastatic Workup, Current Respiratory Medicine Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573398X14666180510143814
DOI https://dx.doi.org/10.2174/1573398X14666180510143814 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytotoxic Potential of Phenothiazines
Current Drug Targets Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Current Medicinal Chemistry Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine Genomics-Based Identification of Molecular Mechanisms behind the Cancer Preventive Action of Phytochemicals: Potential and Challenges
Current Pharmaceutical Biotechnology Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery Decreased lncRNA SNHG16 Accelerates Oxidative Stress Induced Pathological Angiogenesis in Human Retinal Microvascular Endothelial Cells by Regulating miR-195/mfn2 Axis
Current Pharmaceutical Design HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Bleomycin and its Role in Inducing Apoptosis and Senescence in Lung Cells - Modulating Effects of Caveolin-1
Current Cancer Drug Targets Regulation and Function of Antimicrobial Peptides in Immunity and Diseases of the Lung
Protein & Peptide Letters Editorial [ Hot topic:Updates on Therapeutic Approaches to Inflammatory Skin Diseases: From Molecular Targets to Drug Development. Part I (Guest Editors: L. Korkina & S. Pastore) ]
Current Drug Metabolism Neuroendocrine Tumors of the Lung: Hystological Classification, Diagnosis, Traditional and New Therapeutic Approaches
Current Medicinal Chemistry Curcumin and its Formulations: Potential Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry Transcriptional Control of the Oxidative Stress Response and Implications of Using Plant Derived Molecules for Therapeutic Interventions in Cancer
Current Medicinal Chemistry Patents in Cancer Stem Cells
Recent Patents on Biomarkers Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Review of MiRNA-Disease Association Prediction
Current Protein & Peptide Science Anticancer Antioxidant Regulatory Functions of Phytochemicals
Current Medicinal Chemistry Phytochemical Screening and In-Vitro Antibacterial and Anticancer Activity of Crude Extract of <i>Matricaria aurea</i>
Current Pharmaceutical Design